Our case studies and publications provide an inside look at how our products and solutions have been used to meet diverse hospital needs.
Take a few minutes to explore the topics below and see how our solutions can give you the peace of mind to meet your sanitization goals. Read our case studies from sterile processing thought leaders at Nevoa, as well as industry-specific publications.
Healthcare Associated Infections (HAIs) are an enormous problem for patients and acute healthcare facilities. To reduce HAIs, many hospitals are employing innovative technology to supplement manual cleaning practices in their quest to combat pathogens in their facility. Whole room fogging technology and UVC light technology are two technologies being used in today’s healthcare environments.
Healthcare Associated Infections (HAIs) are a huge problem for patients and acute healthcare facilities. The impact of HAIs is detrimental to patient outcomes and increases the cost of provider care. In hospitals alone, the Centers for Disease Control and Prevention (CDC) estimate HAIs account for 1.7 million infections and more than 98,000 deaths each year.1 Approximately $45 billion in direct hospital costs are associated annually for the treatment of HAIs.2 Hospital environment, health care staff, visitors and patient medical conditions are contributing factors to the development of HAIs.
Nevoa® is a healthcare innovation company dedicated to reducing the impact of hospital acquired infections (HAIs) through better disinfection technology.
Nevoa saw a need to reduce human error and cross-contamination common to manual disinfection protocols. Nevoa developed a system consisting of a proprietary hypochlorous acid (HOCl) solution called Nevoa Microburst SolutionTM and an automated robot called NimbusTM. The patented Nimbus device atomizes (fogs) the disinfectant for whole-room disinfection including 100% of a room’s surfaces as well as room air. This system is the only US Environmental Protection Agency (EPA) registered disinfectant approved for fogging HOCl in healthcare environments. Rigorous testing has been conducted through independent laboratories to provide the necessary validation studies for EPA registration. Additional studies have also been conducted to demonstrate efficacy against several specific pathogens of interest.
Enter your email address to register
to our newsletter subscription!